Podcast Services: Apple Podcasts • Google Podcasts • Spotify Podcasts
Dr. Lenze discusses a clinical trial conducted by Washington University School of Medicine in St. Louis which evidences the potential that fluvoxamine, an antidepressant, may prevent COVID-19 infections from worsening. This trial is based on recent research that originates from the University of Virginia School of Medicine.
Website: https://stopcovidtrial.wustl.edu/
Phone: 314-747-1137
Email: [email protected]